Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Main subject
Language
Document Type
Year range
1.
Emerg Infect Dis ; 29(1): 226-228, 2023 01.
Article in English | MEDLINE | ID: covidwho-2198456

ABSTRACT

During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.


Subject(s)
COVID-19 , Humans , Fiji/epidemiology , COVID-19/epidemiology , SARS-CoV-2 , Seroepidemiologic Studies , Antibodies, Viral
SELECTION OF CITATIONS
SEARCH DETAIL